{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:26:46Z","timestamp":1777922806224,"version":"3.51.4"},"reference-count":26,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:p>\n                    The antibiotic, trimethoprim\u2013sulfamethoxazole (TMP-SMX), is generally used for prophylaxis in HIV individuals to protect them from\n                    <jats:italic toggle=\"yes\">Pneumocystis jiroveci<\/jats:italic>\n                    infection. Long-term use of TMP-SMX develops drug resistance among bacteria in HIV patients. The study was aimed to detect the TMP-SMX resistance genes among gram-negative bacteria from HIV patients. TMP-SMX-resistant isolates were detected by the Kirby-Bauer disc diffusion method. While TMP resistance genes such as\n                    <jats:italic toggle=\"yes\">dfrA1<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">dfrA5<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">dfrA7<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">dfrA17<\/jats:italic>\n                    and SMX resistance genes such as\n                    <jats:italic toggle=\"yes\">sul1<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">sul2<\/jats:italic>\n                    were detected by multiplex PCR, class 1 and class 2 integrons were detected by standard monoplex PCR. Of the 151 TMP-SMX-resistant bacterial isolates, 3 were positive for\n                    <jats:italic toggle=\"yes\">sul1<\/jats:italic>\n                    alone, 48 for\n                    <jats:italic toggle=\"yes\">sul2<\/jats:italic>\n                    alone, 11 for\n                    <jats:italic toggle=\"yes\">dfrA7<\/jats:italic>\n                    alone, 21 for\n                    <jats:italic toggle=\"yes\">sul1<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">sul2<\/jats:italic>\n                    , 1 for\n                    <jats:italic toggle=\"yes\">sul1<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">dfrA7<\/jats:italic>\n                    , 23 for\n                    <jats:italic toggle=\"yes\">sul2<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">dfrA7<\/jats:italic>\n                    , 2 for\n                    <jats:italic toggle=\"yes\">sul2<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">dfrA5<\/jats:italic>\n                    , 41 for\n                    <jats:italic toggle=\"yes\">sul1<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">sul2<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">dfrA7<\/jats:italic>\n                    , and 1 for s\n                    <jats:italic toggle=\"yes\">ul2<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">dfrA5<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">dfrA7<\/jats:italic>\n                    . Of 60 TMP-SMX-resistant isolates positive for integrons, 44 had class 1 and 16 had class 2 integrons. It was found that the prevalence of\n                    <jats:italic toggle=\"yes\">sul<\/jats:italic>\n                    genes (\n                    <jats:italic toggle=\"yes\">n<\/jats:italic>\n                    \u2009=\u2009202;\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    \u2009&lt;\u20090.001) was higher compared with\n                    <jats:italic toggle=\"yes\">dfr<\/jats:italic>\n                    genes (\n                    <jats:italic toggle=\"yes\">n<\/jats:italic>\n                    \u2009=\u200980;\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    \u2009&lt;\u20090.001), and 87.4% (\n                    <jats:italic toggle=\"yes\">n<\/jats:italic>\n                    \u2009=\u2009132;\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    \u2009&lt;\u20090.001) of TMP-SMX-resistant isolates also were positive for \u03b2-lactamase production. This type of study is reported for the first time from HIV patients in India. Therefore, this study indicates that dissemination of TMP-SMX resistance genes and class 1 and class 2 integrons along with \u03b2-lactamase production among gram-negative bacteria in HIV patients will certainly make their treatment to bacterial infections more complicated in clinical settings.\n                  <\/jats:p>","DOI":"10.1089\/mdr.2016.0034","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T10:31:22Z","timestamp":1479378682000},"page":"602-608","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":13,"title":["Dissemination of Trimethoprim\u2013Sulfamethoxazole Drug Resistance Genes Associated with Class 1 and Class 2 Integrons Among Gram-Negative Bacteria from HIV Patients in South India"],"prefix":"10.1177","volume":"23","author":[{"given":"Marimuthu Ragavan","family":"Ramesh Kumar","sequence":"first","affiliation":[{"name":"Presidency College (Autonomous)","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narasingam","family":"Arunagirinathan","sequence":"additional","affiliation":[{"name":"Presidency College (Autonomous)","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seetharaman","family":"Srivani","sequence":"additional","affiliation":[{"name":"University of Madras","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aridoss","family":"Dhanasezhian","sequence":"additional","affiliation":[{"name":"University of Madras","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nallusamy","family":"Vijaykanth","sequence":"additional","affiliation":[{"name":"Presidency College (Autonomous)","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natesan","family":"Manikandan","sequence":"additional","affiliation":[{"name":"Presidency College (Autonomous)","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sethuramalingam","family":"Balakrishnan","sequence":"additional","affiliation":[{"name":"Presidency College (Autonomous)","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramachandran","family":"Vignesh","sequence":"additional","affiliation":[{"name":"Voluntary Health Services Hospital Campus","place":["India"]},{"name":"Universiti Kuala Lumpur Royal College of Medicine Perak (UniKL RCMP)","place":["Malaysia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pachamuthu","family":"Balakrishnan","sequence":"additional","affiliation":[{"name":"Voluntary Health Services Hospital Campus","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suniti","family":"Solomon","sequence":"additional","affiliation":[{"name":"Voluntary Health Services Hospital Campus","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil S.","family":"Solomon","sequence":"additional","affiliation":[{"name":"Voluntary Health Services Hospital Campus","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2017,7]]},"reference":[{"key":"e_1_3_2_2_2","first-page":"1","article-title":"Surveillance for AIDS-defining opportunistic illnesses, 1992\u20131997","volume":"48","author":"Jones J.L.","year":"1999","unstructured":"Jones J.L., , Hanson D.L., , Dworkin M.S., , Aldeston D.L., , Fleming P.L., , Kaplan J.E., , and Ward J.. 1999. Surveillance for AIDS-defining opportunistic illnesses, 1992\u20131997. MMWR CDC Surveill. Summ., 48:1\u201322.","journal-title":"MMWR CDC Surveill. Summ."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199212243272604","article-title":"A controlled trial of trimethoprim- sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021","volume":"327","author":"Hardy W.D.","year":"1992","unstructured":"Hardy W.D., , Feinberg J., , Finkelstein D.M., , Power M.E., , He W., , Kaczka C., , Frame P.T., , Holmes M., , Waskin H., , Fass R.J., , and Powderly W.G.. 1992. A controlled trial of trimethoprim- sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N. Engl. J. Med., 327:1842\u20131848.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17442-4"},{"key":"e_1_3_2_5_2","unstructured":"World Health Organization. 2000. Provisional WHO\/UNAIDS Secretariat Recommendations on the Use of Cotrimoxazole Prophylaxis in Adults and Children Living with HIV\/AIDS in Africa. WHO\/UNAIDS Geneva Switzerland."},{"key":"e_1_3_2_6_2","unstructured":"World Health Organization. 2006. Guidelines on Co-trimoxazole Prophylaxis for HIV Related Infections Among Children Adolescents and Adults: Recommendations for a Public Health Approach. WHO\/UNAIDS Geneva Switzerland."},{"key":"e_1_3_2_7_2","first-page":"1809","article-title":"Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era","volume":"180","author":"Martin J.N.","year":"1999","unstructured":"Martin J.N., , Rose D.A., , Hadley W.K., , Perdreau-Remington F., , Lam P.K., , and Gerberding J.L.. 1999. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era. Clin. Infect. Dis., 180:1809\u20131818.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1462"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2334-14-S3-P57","article-title":"Trimethoprim sulfamethoxazole drug resistance with co-resistance to extended spectrum \u03b2-lactam antibiotics among bacterial isolates from HIV patients","volume":"14","author":"Rameshkumar M.R.","year":"2014","unstructured":"Rameshkumar M.R., , Vijaykanth N., , Vignesh R., , Balakrishnan P., , Solomon S., , and Arunagirinathan N.. 2014. Trimethoprim sulfamethoxazole drug resistance with co-resistance to extended spectrum \u03b2-lactam antibiotics among bacterial isolates from HIV patients. BMC Infect. Dis., 14:57.","journal-title":"BMC Infect. Dis."},{"key":"e_1_3_2_10_2","unstructured":"National AIDS Control Organization. 2007. Guidelines for HIV Testing. NACO Government of India New Delhi pp. 39\u201340."},{"key":"e_1_3_2_11_2","unstructured":"Clinical and Laboratory Standards Institute (CLSI). 2012. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement (M100-S21). CLSI Wayne PA."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkf164"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1017\/S0950268804003048","article-title":"Genetic analysis of antibiotic- resistance determinants in multidrug-resistant Shigella strains isolated from Chilean children","volume":"133","author":"Toro C.S.","year":"2005","unstructured":"Toro C.S., , Farfan M., , Contreras I., , Flores O., , Navarro N., , Mora G.C., , and Prado V.. 2005. Genetic analysis of antibiotic- resistance determinants in multidrug-resistant Shigella strains isolated from Chilean children. Epidemiol. Infect., 133:81\u201386.","journal-title":"Epidemiol. Infect."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1469-0691.2007.01807.x","article-title":"Standard and real-time multiplex PCR methods for detection of trimethoprim resistance dfr genes in large collections of bacteria","volume":"13","author":"Grape M.","year":"2007","unstructured":"Grape M., , Motakefi A., , Pavuluri S., , and Kahlmeter G.. 2007. Standard and real-time multiplex PCR methods for detection of trimethoprim resistance dfr genes in large collections of bacteria. Clin. Microbiol. Infect., 13:1112\u20131118.","journal-title":"Clin. Microbiol. Infect."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/AAC.49.5.1823-1829.2005","article-title":"Integron content of extended-spectrum-\u03b2-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain","volume":"49","author":"Machado E.","year":"2005","unstructured":"Machado E., , Cant\u00f3n R., , Baquero F., , Gal\u00e1n J.C., , Roll\u00e1n A., , Peixe L., , and Coque T.M.. 2005. Integron content of extended-spectrum-\u03b2-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain. Antimicrob. Agents Chemother., 49:1823\u20131829.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1128\/AAC.46.12.3829-3836.2002","article-title":"Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coli","volume":"46","author":"Oliver A.","year":"2002","unstructured":"Oliver A., , Weigel L.M., , Rasheed J.K., , McGowan J.E.Jr, , Raney P., , and Tenover F.C.. 2002. Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coli. Antimicrob. Agents Chemother., 46:3829\u20133836.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.9.4264-4269.2003"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/JCM.40.6.2153-2162.2002","article-title":"Detection of plasmid-mediated AmpC \u03b2-lactamase genes in clinical isolates by using Multiplex PCR","volume":"40","author":"P\u00e9rez-P\u00e9rez F.J.","year":"2002","unstructured":"P\u00e9rez-P\u00e9rez F.J., and Hanson N.D.. 2002. Detection of plasmid-mediated AmpC \u03b2-lactamase genes in clinical isolates by using Multiplex PCR. J. Clin. Microbiol., 40:2153\u20132162.","journal-title":"J. Clin. Microbiol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jac\/dkl481","article-title":"Multiplex PCR for rapid detection of genes encoding acquired metallo \u03b2-lactamases","volume":"59","author":"Ellington M.J.","year":"2007","unstructured":"Ellington M.J., , Kistler J., , Livermore D.M., , and Woodford N.. 2007. Multiplex PCR for rapid detection of genes encoding acquired metallo \u03b2-lactamases. J. Antimicrob. Chemother., 59:321\u2013322.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1099\/jmm.0.011080-0","article-title":"Multiplex PCR for rapid detection of genes encoding OXA and metallo-beta-lactamases in carbapenem resistant Acinetobacter spp","volume":"58","author":"Mostachio A.K.","year":"2009","unstructured":"Mostachio A.K., , Heidjen I.V., , Rossi F., , Levin A.S., , and Costa S.F.. 2009. Multiplex PCR for rapid detection of genes encoding OXA and metallo-beta-lactamases in carbapenem resistant Acinetobacter spp. J. Med. Microbiol., 58:1552\u20131554.","journal-title":"J. Med. Microbiol."},{"key":"e_1_3_2_21_2","first-page":"122","article-title":"Multi-drug resistant Escherichia coli from human immunodeficiency virus\/acquired immunodeficiency syndrome (HIV\/AIDS) patients in Keffi, Nigeria","volume":"2","author":"Ngwai Y.B.","year":"2011","unstructured":"Ngwai Y.B., , Nwan Kwo H.N., , and Adoga M.P.. 2011. Multi-drug resistant Escherichia coli from human immunodeficiency virus\/acquired immunodeficiency syndrome (HIV\/AIDS) patients in Keffi, Nigeria. Int. Res. J. Microbiol., 2:122\u2013125.","journal-title":"Int. Res. J. Microbiol."},{"key":"e_1_3_2_22_2","first-page":"54","article-title":"Detection of extended-spectrum \u03b2 lactamases and AmpC \u03b2-lactamase production in Escherichia coli causing urinary tract infection among HIV and non-HIV patients","volume":"1","author":"Padmavathy K.","year":"2011","unstructured":"Padmavathy K., , Padma K., , and Rajasekaran S.. 2011. Detection of extended-spectrum \u03b2 lactamases and AmpC \u03b2-lactamase production in Escherichia coli causing urinary tract infection among HIV and non-HIV patients. American Med. J., 1:54\u201358.","journal-title":"American Med. J."},{"key":"e_1_3_2_23_2","unstructured":"Grabe M. Bjerklund-Johansen T.E. Botto H. \u00c7ek M. Naber K.G. Pickard R.S. Tenke P. Wagenlehner F. and Wullt B.. 2013. Guidelines on Urological Infections (NL-6803 AA ARNHEM). European Association of Urology The Netherlands pp. 146\u2013162."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/103874"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.03010.x"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.2.836-839.2005"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2009.0091"}],"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mdr.2016.0034","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2016.0034","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2016.0034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:30:28Z","timestamp":1777667428000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/mdr.2016.0034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1089\/mdr.2016.0034"],"URL":"https:\/\/doi.org\/10.1089\/mdr.2016.0034","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}